Stay updated on NanoTherm for Intermed Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the NanoTherm for Intermed Prostate Cancer Clinical Trial page.

Latest updates to the NanoTherm for Intermed Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedAn NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the detailed study content with an access-denied screen. This change prevents viewing the trial’s key details and locations.SummaryDifference16%

- Check39 days agoChange DetectedProstate cancer was added to the related topics, and MedlinePlus Genetics appears as a related topic, expanding the page's contextual links. The footer revision was updated from v3.6.6 to v3.7.0.SummaryDifference0.3%

- Check46 days agoChange DetectedDeleted the disease label 'Prostate cancer' and the 'related topics' section, including the MedlinePlus Genetics link. This reduces explicit context about the study's focus and the related educational resources on the condition.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now includes the Prostate cancer topic and related topic MedlinePlus Genetics. The footer revision label updates to v3.6.6, replacing v3.6.5.SummaryDifference0.3%

Stay in the know with updates to NanoTherm for Intermed Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NanoTherm for Intermed Prostate Cancer Clinical Trial page.